Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.
Principal International Equity Index R1 PILIX
- NAV / 1-Day Return 12.25 / +2.42 %
- Total Assets 1.2 Bil
-
Adj. Expense Ratio
- Expense Ratio 1.210%
- Distribution Fee Level Below Average
- Share Class Type Retirement, Medium
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment 0
- Status Limited
- TTM Yield 1.49%
- Turnover 38%
USD | NAV as of Sep 27, 2024 | 1-Day Return as of Sep 27, 2024, 12:14 AM GMT+0
Morningstar’s Analysis PILIX
Will PILIX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 16.5
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
iShares MSCI EAFE ETF | 2.72 | 32.6 Mil | — |
Novo Nordisk AS Class B | 2.48 | 29.8 Mil | Healthcare |
ASML Holding NV | 2.00 | 24.0 Mil | Technology |
Nestle SA | 1.56 | 18.7 Mil | Consumer Defensive |
AstraZeneca PLC | 1.51 | 18.1 Mil | Healthcare |
Novartis AG Registered Shares | 1.32 | 15.8 Mil | Healthcare |
Roche Holding AG | 1.32 | 15.8 Mil | Healthcare |
SAP SE | 1.27 | 15.2 Mil | Technology |
Shell PLC | 1.24 | 14.9 Mil | Energy |
Lvmh Moet Hennessy Louis Vuitton SE | 1.13 | 13.6 Mil | Consumer Cyclical |